K
Kairos
Kairos is a seed to Series D stage investment firm. It has made 9 investments. Their most common stage is seed (40% of deals). Average disclosed round size is $11.4M (across 8 rounds with reported amounts).
Portfolio
9
Fund Size
—
Top Stage
Seed
Last 12 Mo
0
Team
DY
Diana Yang
Managing Director, Investor Relations
RV
Ramon Verastegui
Managing Director and Chief Investment Officer
CC
Carl C.
CEO and Founder of Kairos Investment Management
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
10 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Foldax | Series D | $20M | Jan 2020 |
 Actuate Therapeutics | Series B | $21.7M | Nov 2019 |
| Foldax | Unknown | $10.3M | Jan 2018 |
| IiBeat | Seed | $5.5M | Aug 2016 |
 Axial Biotherapeutics | Series A | $19.1M | Jan 2016 |
 LogX | Seed | $4M | — |
| RRoslin Tech | Series A | — | — |
| AAlomana | Seed | $4.7M | — |
| MMyVillage | Seed | $6M | — |
| UUnderscore District | Unknown | — | — |
Top Co-Investors
MemorialCare Innovation Fund2 shared
8VC1 shared
Band of Angels1 shared
Plug&Play1 shared
Oakhouse Partners1 shared
City Light Capital1 shared
TCA Venture Group1 shared
Tech Coast Angels1 shared
IOSG1 shared
Gate Labs1 shared
IOSG Ventures1 shared
Saison Capital1 shared
Coinbase Ventures1 shared
Antler1 shared
Better Capital1 shared
Sequoia Capital1 shared
Summation Health Ventures1 shared
Domain Associates1 shared
Longwood Fund1 shared
Novo Holdings1 shared
Last updated: 8 September 2026